Bone infection, also known as osteomyelitis, is a serious condition characterized by the inflammation or infection of bone tissue. This can result from bacteria entering the bone through open fractures, surgical procedures, or bloodstream infections. Common causative bacteria include Staphylococcus aureus. Symptoms of bone infection may include localized pain, swelling, redness, and limited joint mobility. Systemic symptoms like fever and chills can also occur. Chronic or untreated cases may lead to bone destruction and the formation of abscesses. Diagnosis involves medical imaging, blood tests, and sometimes bone biopsies to identify the causative bacteria. Treatment typically includes prolonged courses of antibiotics, and in severe cases, surgical intervention may be necessary to remove infected tissue. Risk factors for bone infections include diabetes, immunocompromised conditions, and the presence of prosthetic devices. Preventive measures involve proper wound care, infection control practices during surgery, and managing underlying health conditions. Early detection and appropriate treatment are essential in managing bone infections and preventing complications. A multidisciplinary approach involving orthopedic surgeons and infectious disease specialists is often required for optimal outcomes.
Title : A promising novel approach to DNA vaccines
Khursheed Nadeem Anwer, IMUNON, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : The importance of post-marketing surveillance and real-world data for a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Advances in vaccines: Revolutionizing disease prevention
Delia Teresa Sponza, Dokuz Eylul University, Turkey